Compare ENTX & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTX | GPRO |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.4M | 166.3M |
| IPO Year | 2015 | 2014 |
| Metric | ENTX | GPRO |
|---|---|---|
| Price | $3.14 | $0.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | 390.9K | ★ 6.1M |
| Earning Date | 11-06-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.08 |
| EPS | ★ 0.33 | N/A |
| Revenue | $42,000.00 | ★ $651,542,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $35.48 |
| P/E Ratio | $9.68 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $0.57 |
| 52 Week High | $4.20 | $2.05 |
| Indicator | ENTX | GPRO |
|---|---|---|
| Relative Strength Index (RSI) | 55.16 | 20.51 |
| Support Level | $2.76 | $0.58 |
| Resistance Level | $3.56 | $0.65 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 47.22 | 0.09 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.